Incidence trends and mortality rates of gastric cancer in Israel

Abstract

Background Gastric cancer is the fourth most common malignancy worldwide. The incidence trends and mortality rates of gastric cancer in Israel have not been studied in depth. The aim of our study was to try and investigate the aforementioned issues in Israel in different ethnic groups. Methods This retrospective study is based on the data of The Israel National Cancer Registry and The Central Bureau of Statistics. Published data from these two institutes were collected, summarized, and analyzed in this study. Results Around 650 new cases of gastric cancer are diagnosed yearly in Israel. While we noticed a decline during the period 1990-2007 in the incidence in the Jewish population (13.6-8.9 and 6.75-5.42 cases per 100,000 in Jewish men and women, respectively), an increase in the Arab population was noticed (7.7-10.2 and 3.7-4.2 cases per 100,000 in men and women, respectively). Ageadjusted mortality rates per 10,000 cases of gastric cancer decreased significantly, from 7.21 in 1990 to 5.46 in 2007, in the total population. The 5-year relative survival showed a slight increase for both men and women. Conclusion There is a difference in the incidence and outcome of gastric cancer between the Jewish and Arab populations in Israel. The grim prognosis of gastric cancer patients in Israel is probably due to the advanced stage at which gastric cancer is diagnosed in Israel.

Body mass index at adolescence and risk of noncardia gastric cancer in a cohort of 1.79 million men and women

“…3 Although most studies suggest a positive association between the BMI and cancer of the gastric cardia (CGC), 4-7 data from meta-analyses have indicated no association between obesity and noncardia gastric cancer (NCGC). 8 In Israel, the age-standardized incidence declined to a rate of 9.7 per 100,000 in 2012, 9,10 with a high incidence of gastric cancer among immigrants from the former Soviet Union (FSU). 8 In Israel, the age-standardized incidence declined to a rate of 9.7 per 100,000 in 2012, 9,10 with a high incidence of gastric cancer among immigrants from the former Soviet Union (FSU).…”

“…8 In Israel, the age-standardized incidence declined to a rate of 9.7 per 100,000 in 2012, 9,10 with a high incidence of gastric cancer among immigrants from the former Soviet Union (FSU). 9 In light of the increasing prevalence of adolescent obesity in Israel, 2,12,13 concern about gastric cancer among immigrants from the FSU, 11 and a report on the association of the BMI with NCGC, 8 we expanded our previous research on the association between the measured BMI, country of birth, and residential socioeconomic status (SES) in adolescence and the risk of gastric cancer among men. 9 In light of the increasing prevalence of adolescent obesity in Israel, 2,12,13 concern about gastric cancer among immigrants from the FSU, 11 and a report on the association of the BMI with NCGC, 8 we expanded our previous research on the association between the measured BMI, country of birth, and residential socioeconomic status (SES) in adolescence and the risk of gastric cancer among men.…”

“…5,7 Yet, a recent study reported a positive association between the BMI and gastric body dysplasia and NCGC, regardless of the Helicobacter pylori status. 8 In Israel, the age-standardized incidence declined to a rate of 9.7 per 100,000 in 2012, 9,10 with a high incidence of gastric cancer among immigrants from the former Soviet Union (FSU). 11 Because of the worldwide immigration of Jews, Israel provides valuable opportunities for epidemiological studies.…”

Incidence and mortality of stomach cancer in Shandong Province in 2012

“…The M/I of stomach cancer was 2.56‐fold higher in Shandong than in Korea (0.69/0.27). The Incidence and mortality of stomach cancer were also much higher in Shandong Province than in other countries in Asia, such as Iran, Israel, and Bhutan . This indicated that the situation of stomach cancer control and prevention was very serious, and measures taken to improve cancer survival rates and reduce mortality were also important in Shandong Province.…”

Prospective randomized phase II study of FOLFIRI versus FOLFOX7 in advanced gastric adenocarcinoma: A Chinese Western Cooperative Gastrointestinal Oncology Group study.

“…Although the incidence and mortality rates have declined worldwide, as the most common cancer, gastric cancer (GC) still ranks fourth in incidence and second in annual cancer-related deaths [1]. Approximately 70% of new cases and deaths occur in developing countries, and the number of Chinese GC patients(pts) accounts for 35-42% of cases worldwide [2,3].…”